Med tech company Occuity has announced the signing of several distributor partnership agreements with leading ophthalmic distributors across the UK and Europe ahead of the launch of the PM1 Pachymeter in summer 2023.
The PM1 Pachymeter, developed by Occuity, offers numerous benefits to the ophthalmic community.
Former Apple industrial designer, Daniele De Illuis, and his team have created a streamlined design and intuitive user experience.
The non-contact, handheld device enables central corneal thickness measurements to be made in seconds.
Occuity CEO, Dan Daly, said: “We are looking forward to introducing the PM1 to the market.
“Having completed successful clinical trials and submitted for CE certification, we are confident in its exceptional performance.
“Through discussions with distributors across Europe, we believe there will be significant demand for the PM1 and have therefore carefully chosen partners who share our dedication to delivering exceptional ophthalmic devices.”
In the UK, Occuity has partnered with Birmingham Optical, a distributor offering a range of leading brands.
Amanda Higginbotham, Chief Commercial Officer at Birmingham Optical, said: “We are thrilled to partner with Occuity and be part of introducing the PM1 to the UK market.
“With their non-contact, handheld platform, Occuity have an exciting pipeline of future products including the AX1 Axiometer for Myopia Management, and we look forward to working with them.”
Occuity has also signed distributor agreements with several other ophthalmic companies across Europe including E. Janach in Italy, bon Optic in Germany, Medilens for the Nordics (Sweden, Denmark, and Norway), Iogen Oy, for Finland, Latvia and Estonia.
Antonello Spinnato, Global Managing Director at E. Janach, said: “Occuity has delivered an excellent product with clear advantages of existing options.
“We believe that the PM1 Pachymeter has the potential to become the primary method of measuring central corneal thickness and are excited to offer this ground-breaking technology to our customers.”
Occuity is also in discussions with distributors to cover APAC and North American territories.
AI helps cut nuisance alerts for healthcare teams
Stabilising the NHS – it’s going to take a lot more than AI
Answer Digital enables speedy deployment of AI with strategic partnerships
Transforming NHS procurement: How good data holds the key to integrated care
British tech firm gets green light on fibroids patent
Cancer leaders pen ‘letter to the world’ calling for urgent investment
Generative AI used to create translatable paediatric care videos for LMIC hospitals
NHS Forth Valley goes live with RCPCH GrowthAPI integrated with Morse Mobile EPR
Mid and South Essex ICS building new shared care record with Orion Health
Red light can reduce blood glucose levels, study finds
- Research3 weeks ago
3D-printed human brain tissue could advance Alzheimer’s research
- News1 week ago
Don’t miss this final chance to nominate your health tech heroes
- News4 weeks ago
Cutting-edge tech to optimise stereotactic radiosurgery demonstrated live at Arab Health
- AI2 weeks ago
AI helps to predict whether antidepressants will work